DDInter1247 DDInter1016
Moxifloxacin is a synthetic fluoroquinolone antibiotic agent. Bayer AG developed the drug (initially called BAY 12-8039) and it is marketed worldwide (as the hydrochloride) under the brand name Avelox (in some countries also Avalox) for oral treatment.
Lactitol, also known as 4-β-D-galactopyranosyl-D-glucitol, is a sugar alcohol synthesized from [lactose]. It is used in food manufacturing as a nutritive sweetener and is approximately 35% as sweet as table sugar (i.e. [sucrose]). Clinically, lactitol has been investigated for use as an osmotic laxative and, along with other non-absorbable disaccharides such as [lactulose], in the treatment of hepatic encephalopathy in patients with cirrhosis.[A190915,A190918] Pizensy, an oral lactitol powder for solution, was approved by the FDA for use in chronic idiopathic constipation in February 2020.
Moxifloxacin {u} (Compound) resembles {v} (Compound) Sparfloxacin
Moxifloxacin {u} (Compound) binds {v} (Gene) TOP2A
Moxifloxacin {u} (Compound) palliates {v} (Disease) chronic obstructive pulmonary disease
Moxifloxacin {u} (Compound) is included by {v} (Pharmacologic Class) Quinolones
Moxifloxacin {u} (Compound) causes {v} (Side Effect) Oedema
Moxifloxacin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Lomustine
Moxifloxacin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Denileukin diftitox
Moxifloxacin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Calcium acetate
Moxifloxacin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Asparaginase Escherichia coli
Moxifloxacin {u} may lead to a major life threatening interaction when taken with {v} Eribulin
Moxifloxacin (Compound) resembles Sparfloxacin (Compound)
Moxifloxacin (Compound) binds TOP2A (Gene)
Moxifloxacin (Compound) palliates chronic obstructive pulmonary disease (Disease)
Moxifloxacin (Compound) is included by Quinolones (Pharmacologic Class)
Moxifloxacin (Compound) causes Oedema (Side Effect)
Moxifloxacin may cause a minor interaction that can limit clinical effects when taken with Lomustine
Moxifloxacin may cause a minor interaction that can limit clinical effects when taken with Denileukin diftitox
Moxifloxacin may cause a moderate interaction that could exacerbate diseases when taken with Calcium acetate
Moxifloxacin may cause a moderate interaction that could exacerbate diseases when taken with Asparaginase Escherichia coli
Moxifloxacin may lead to a major life threatening interaction when taken with Eribulin